These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 24602902)
1. Design, synthesis and biological evaluation of new inhibitors of Bax/Bcl-xL interaction in cancer cells. Vo DD; Gautier F; Barillé-Nion S; Juin P; Levoin N; Grée R Bioorg Med Chem Lett; 2014 Apr; 24(7):1758-61. PubMed ID: 24602902 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of selected polyphenol derivatives as inhibitors of Bax/Bcl-xL interaction. Vo DD; Gautier F; Juin P; Grée R Eur J Med Chem; 2012 May; 51():286-93. PubMed ID: 22425031 [TBL] [Abstract][Full Text] [Related]
3. Preliminary Studies on the Activity of Mixed Polyphenol-Heterocyclic Systems Against B16-F10 Melanoma Cancer Cells. Duy Vo D; Rouaud I; Le Devehat F; Gautier F; Barillé-Nion S; Juin P; Levoin N; Boustie J; Grée R Med Chem; 2016; 12(5):419-25. PubMed ID: 26825069 [TBL] [Abstract][Full Text] [Related]
4. Identification of inhibitors of Bcl-2 family protein-protein interaction by combining the BRET screening platform with virtual screening. Park IS; Seo HR; Kim K; Lee H; Shum D; Choi I; Kim J Biochem Biophys Res Commun; 2020 Jun; 527(3):709-715. PubMed ID: 32423828 [TBL] [Abstract][Full Text] [Related]
5. Discovery of potent and selective benzothiazole hydrazone inhibitors of Bcl-XL. Sleebs BE; Kersten WJ; Kulasegaram S; Nikolakopoulos G; Hatzis E; Moss RM; Parisot JP; Yang H; Czabotar PE; Fairlie WD; Lee EF; Adams JM; Chen L; van Delft MF; Lowes KN; Wei A; Huang DC; Colman PM; Street IP; Baell JB; Watson K; Lessene G J Med Chem; 2013 Jul; 56(13):5514-40. PubMed ID: 23767404 [TBL] [Abstract][Full Text] [Related]
6. A combination of in silico and SAR studies to identify binding hot spots of Bcl-xL inhibitors. Levoin N; Vo DD; Gautier F; Barillé-Nion S; Juin P; Tasseau O; Grée R Bioorg Med Chem; 2015 Apr; 23(8):1747-57. PubMed ID: 25797160 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity. Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071 [TBL] [Abstract][Full Text] [Related]
8. The cell death machinery controlled by Bax and Bcl-XL is evolutionarily conserved in Ciona intestinalis. Takada N; Yamaguchi H; Shida K; Terajima D; Satou Y; Kasuya A; Satoh N; Satake M; Wang HG Apoptosis; 2005 Dec; 10(6):1211-20. PubMed ID: 16215691 [TBL] [Abstract][Full Text] [Related]
9. The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation. Schmitt E; Sané AT; Steyaert A; Cimoli G; Bertrand R Biochem Cell Biol; 1997; 75(4):301-14. PubMed ID: 9493953 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and interaction study of quinazoline-2(1H)-thione derivatives as novel potential Bcl-xL inhibitors. Feng Y; Ding X; Chen T; Chen L; Liu F; Jia X; Luo X; Shen X; Chen K; Jiang H; Wang H; Liu H; Liu D J Med Chem; 2010 May; 53(9):3465-79. PubMed ID: 20405848 [TBL] [Abstract][Full Text] [Related]
11. Identification of a phenylacylsulfonamide series of dual Bcl-2/Bcl-xL antagonists. Perez HL; Banfi P; Bertrand J; Cai ZW; Grebinski JW; Kim K; Lippy J; Modugno M; Naglich J; Schmidt RJ; Tebben A; Vianello P; Wei DD; Zhang L; Galvani A; Lombardo LJ; Borzilleri RM Bioorg Med Chem Lett; 2012 Jun; 22(12):3946-50. PubMed ID: 22608961 [TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL. El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075 [TBL] [Abstract][Full Text] [Related]
13. Targeting the BH3 domain mediated protein-protein interaction of Bcl-xL through virtual screening. Mukherjee P; Desai P; Zhou YD; Avery M J Chem Inf Model; 2010 May; 50(5):906-23. PubMed ID: 20392095 [TBL] [Abstract][Full Text] [Related]
14. De novo design, synthesis and evaluation of benzylpiperazine derivatives as highly selective binders of Mcl-1. Ding X; Li Y; Lv L; Zhou M; Han L; Zhang Z; Ba Q; Li J; Wang H; Liu H; Wang R ChemMedChem; 2013 Dec; 8(12):1986-2014. PubMed ID: 24124106 [TBL] [Abstract][Full Text] [Related]
15. Discovery of potent Mcl-1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis of target proteins. Tanaka Y; Aikawa K; Nishida G; Homma M; Sogabe S; Igaki S; Hayano Y; Sameshima T; Miyahisa I; Kawamoto T; Tawada M; Imai Y; Inazuka M; Cho N; Imaeda Y; Ishikawa T J Med Chem; 2013 Dec; 56(23):9635-45. PubMed ID: 24215352 [TBL] [Abstract][Full Text] [Related]
16. RACK1 promotes Bax oligomerization and dissociates the interaction of Bax and Bcl-XL. Wu Y; Wang Y; Sun Y; Zhang L; Wang D; Ren F; Chang D; Chang Z; Jia B Cell Signal; 2010 Oct; 22(10):1495-501. PubMed ID: 20541605 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel 1,2,3-triazole derivatives of coronopilin as anti-cancer compounds. Khazir J; Hyder I; Gayatri JL; Prasad Yandrati L; Nalla N; Chasoo G; Mahajan A; Saxena AK; Alam MS; Qazi GN; Sampath Kumar HM Eur J Med Chem; 2014 Jul; 82():255-62. PubMed ID: 24910974 [TBL] [Abstract][Full Text] [Related]
18. Towards the next generation of dual Bcl-2/Bcl-xL inhibitors. Varnes JG; Gero T; Huang S; Diebold RB; Ogoe C; Grover PT; Su M; Mukherjee P; Saeh JC; MacIntyre T; Repik G; Dillman K; Byth K; Russell DJ; Ioannidis S Bioorg Med Chem Lett; 2014 Jul; 24(14):3026-33. PubMed ID: 24881567 [TBL] [Abstract][Full Text] [Related]
19. [Detection and clinical significance of apoptosis related protein in local advanced rectal cancer patients with preoperative neoadjuvant therapy]. Liu Y; Zhang G; Qian J; Zhu YP; Ju HX; Feng HY; Zhu HN; Li DC Zhonghua Wai Ke Za Zhi; 2012 Oct; 50(10):914-7. PubMed ID: 23302463 [TBL] [Abstract][Full Text] [Related]
20. The N-terminus and alpha-5, alpha-6 helices of the pro-apoptotic protein Bax, modulate functional interactions with the anti-apoptotic protein Bcl-xL. Parikh N; Koshy C; Dhayabaran V; Perumalsamy LR; Sowdhamini R; Sarin A BMC Cell Biol; 2007 May; 8():16. PubMed ID: 17519046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]